Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 0.73% | 245.29 | 1.5% | $944.07m | |
| MRNA | Moderna, Inc. | -0.69% | 141.21 | 0.0% | $800.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.82% | 599.32 | 2.6% | $516.26m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.48% | 280.25 | 1.9% | $509.19m | |
| GILD | Gilead Sciences, Inc. | 0.02% | 62.22 | 1.0% | $507.83m | |
| NVAX | Novavax, Inc. | -0.16% | 50.98 | 75.7% | $416.48m | |
| ILMN | Illumina, Inc. | -1.21% | 185.17 | 3.3% | $353.22m | |
| BIIB | Biogen, Inc. | 0.83% | 204.19 | 1.8% | $244.19m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 3.59% | 3.46 | 0.7% | $241.87m | |
| CRSP | CRISPR Therapeutics AG | -0.84% | 62.75 | 0.6% | $168.47m | |
| BNTX | BioNTech SE | 0.90% | 141.08 | 0.0% | $168.39m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.08% | 83.22 | 4.2% | $123.62m | |
| EXAS | EXACT Sciences Corp. | -1.61% | 40.45 | 17.7% | $97.90m | |
| IOVA | Iovance Biotherapeutics, Inc. | -3.01% | 10.65 | 0.0% | $92.77m | |
| TECH | Bio-Techne Corp. | -0.61% | 343.90 | 4.5% | $92.65m |
Company Profile
Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. engages in building a drug development pipeline through the licensing and acquisition of oncology therapeutics in late preclinical and clinical development stages. Its product pipeline includes Validive, Camsirubicin and MNPR-101. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.